<DOC>
	<DOCNO>NCT00487123</DOCNO>
	<brief_summary>This study evaluate efficacy reminder device Remind CapÂ® improve patient ' compliance consumption Valsartan +/- Hydrochlorothiazide ( HCTZ ) treatment hypertension</brief_summary>
	<brief_title>Efficacy New Closure Device Improving Patient Compliance Treatment Hypertension With Valsartan+/-Hydrochlorothiazide ( HCTZ ) 6 Months</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Patients hypertension newly start use Valsartan+/HCTZ Pregnancy Hypersensitivity Valsartan+/HCTZ Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Hypertension , compliance , Valsartan , hydrochlorothiazide ( HCTZ )</keyword>
</DOC>